Vaxcyte, Inc. PCVX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $175.43M-54.9% | $389.2M-2.3% | $398.55M-52.3% | $835.53M+1,111% | ||
| $1.39B+2.0% | $1.36B+99.1% | $682.78M+606% | $96.72M-45.4% | ||
| $1.63B-9.0% | $1.79B+63.1% | $1.1B+16.3% | $942.56M+268% | ||
| $257.37M+30.0% | $198.05M+149% | $79.63M+669% | $10.36M+30.2% | ||
| $1.38B-20.2% | $1.72B+452% | $311.96M+390% | $63.62M-6.4% | ||
| $3B-14.5% | $3.51B+149% | $1.41B+39.9% | $1.01B+210% | ||
| $171.79M+73.8% | $98.85M+69.9% | $58.17M+114% | $27.12M-69.2% | ||
| $205.75M+46.8% | $140.18M-3.5% | $145.34M+259% | $40.53M+41.1% | ||
| $317.21M+54.4% | $205.5M+22.7% | $167.45M+219% | $52.57M+30.4% | ||
| 500M+390,525% | 128K+30.6% | 98K+19.5% | 82K+46.4% | ||
| -$2.15B-55.2% | -$1.39B-50.2% | -$924.39M-77.0% | -$522.13M-74.8% | ||
| $2.69B-18.8% | $3.31B+166% | $1.24B+30.1% | $953.61M+236% | ||
| $3B-14.5% | $3.51B+149% | $1.41B+39.9% | $1.01B+210% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vaxcyte, Inc.'s total assets?
- Vaxcyte, Inc. (PCVX) holds $3.3B in total assets, down 0.9% year over year.
- How much debt does Vaxcyte, Inc. have?
- Vaxcyte, Inc. carries $116.3M in total debt against $3.0B of shareholders' equity, a debt-to-equity ratio of 0.04.
- How much cash does Vaxcyte, Inc. have?
- Vaxcyte, Inc. holds $262.3M in cash and equivalents.
- Can Vaxcyte, Inc. cover its short-term obligations?
- Its current ratio is 7.49 — current assets exceed current liabilities.
- Where does Vaxcyte, Inc.'s balance sheet data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.